Zhao Xiaohui, Luo Ting, Qiu Yuting, Yang Zhiwei, Wang Danni, Wang Zairui, Zeng Jiale, Bi Zhuofei
Department of Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Department of Oncology, Shenshan Medical Centre, Memorial Hospital of Sun Yat-Sen University, Shanwei, China.
Front Oncol. 2024 Jun 27;14:1388750. doi: 10.3389/fonc.2024.1388750. eCollection 2024.
Breast cancer stands as the most prevalent malignancy among women, with radiotherapy serving as a primary treatment modality. Despite radiotherapy, a subset of breast cancer patients experiences local recurrence, attributed to the intrinsic resistance of tumors to radiation. Therefore, there is a compelling need to explore novel approaches that can enhance cytotoxic effects through alternative mechanisms. Traditional Chinese Medicine (TCM) and its active constituents exhibit diverse pharmacological actions, including anti-tumor effects, offering extensive possibilities to identify effective components capable of overcoming radiotherapy resistance. This review delineates the mechanisms underlying radiotherapy resistance in breast cancer, along with potential candidate Chinese herbal medicines that may sensitize breast cancer cells to radiotherapy. The exploration of such herbal interventions holds promise for improving therapeutic outcomes in the context of breast cancer radiotherapy resistance.
乳腺癌是女性中最常见的恶性肿瘤,放射治疗是主要的治疗方式。尽管进行了放射治疗,但一部分乳腺癌患者仍会出现局部复发,这归因于肿瘤对放疗的内在抗性。因此,迫切需要探索能够通过替代机制增强细胞毒性作用的新方法。中药及其活性成分具有多种药理作用,包括抗肿瘤作用,为鉴定能够克服放疗抗性的有效成分提供了广泛的可能性。本综述阐述了乳腺癌放疗抗性的潜在机制,以及可能使乳腺癌细胞对放疗敏感的潜在候选中草药。探索此类草药干预措施有望改善乳腺癌放疗抗性情况下的治疗效果。